The Vanguard Group, Inc.

PRESS RELEASE

published on 03/30/2023 at 14:19, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: Devro plc
PRESS RELEASE

published on 03/30/2023 at 14:17, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE

published on 03/29/2023 at 14:24, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
PRESS RELEASE

published on 03/29/2023 at 14:22, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
PRESS RELEASE

published on 03/29/2023 at 14:21, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
PRESS RELEASE

published on 03/29/2023 at 14:19, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
PRESS RELEASE

published on 03/28/2023 at 14:35, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
PRESS RELEASE

published on 03/28/2023 at 14:33, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
PRESS RELEASE

published on 03/28/2023 at 14:31, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: John Wood Group plc
PRESS RELEASE

published on 03/28/2023 at 14:29, 3 years 5 months ago

Form 8.3 - The Vanguard Group, Inc.: Devro plc

Published on 09/10/2026 at 19:30, 8 hours 1 minute ago

Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 07:00, 20 hours 31 minutes ago

2026 H1 results and new identity
Published on 09/09/2026 at 18:45, 1 day 8 hours ago

Successful launch of a €500 million bond issue
Published on 09/09/2026 at 17:45, 1 day 9 hours ago

Information concerning the total number of voting rights and shares 2026 08 31
Published on 09/09/2026 at 17:45, 1 day 9 hours ago

Report on share repurchases from 7 to 8 September 2026

News